N-(4-chlorophenyl)-2-[[5-(3-phenylpropanoylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]butanamide
TL;DR: N-(4-chlorophenyl)-2-[[5-(3-phenylpropanoylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]butanamide (CAS 535948-24-4) is a chemical compound with molecular formula C21H21ClN4O2S2 and molecular weight 460.08 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
N-(4-chlorophenyl)-2-[[5-(3-phenylpropanoylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]butanamide
Also Known As: N-(4-chlorophenyl)-2-[[5-(3-phenylpropanoylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]butanamide, N-(4-chlorophenyl)-2-({5-[(3-phenylpropanoyl)amino]-1,3,4-thiadiazol-2-yl}sulfanyl)butanamide, N-(4-chlorophenyl)-2-((5-(3-phenylpropanamido)-1,3,4-thiadiazol-2-yl)thio)butanamide, N-(4-chlorophenyl)-2-({(5Z)-5-[(3-phenylpropanoyl)imino]-4,5-dihydro-1,3,4-thiadiazol-2-yl}sulfanyl)butanamide
| Molecular Formula | C21H21ClN4O2S2 |
|---|---|
| Molecular Weight | 460.08 g/mol |
| LogP | 5.2722 |
| Topological Polar Surface Area | 83.98 Ų |
| Hydrogen Bond Donors | 2 |
| Hydrogen Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Exact Mass | 460.07944 |
| Heavy Atoms | 30 |
| Complexity | 980.18616 |
Chemical Identifiers
| CAS Number | 535948-24-4 |
|---|---|
| SMILES | CCC(C(=O)NC1=CC=C(C=C1)Cl)SC2=NN=C(S2)NC(=O)CCC3=CC=CC=C3 |
Product Overview
N-(4-chlorophenyl)-2-[[5-(3-phenylpropanoylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]butanamide (CAS 535948-24-4), with molecular formula C21H21ClN4O2S2 and molecular weight 460.08 g/mol. IUPAC: N-(4-chlorophenyl)-2-[[5-(3-phenylpropanoylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]butanamide.
Chemical Property Profile of N-(4-chlorophenyl)-2-[[5-(3-phenylpropanoylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]butanamide
Property Insights of N-(4-chlorophenyl)-2-[[5-(3-phenylpropanoylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]butanamide
The XLogP value of 5.2722 indicates that N-(4-chlorophenyl)-2-[[5-(3-phenylpropanoylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]butanamide is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 83.98 Ų falls within the moderate polarity range, balancing permeability and solubility for N-(4-chlorophenyl)-2-[[5-(3-phenylpropanoylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]butanamide. Following Lipinski's Rule of Five, N-(4-chlorophenyl)-2-[[5-(3-phenylpropanoylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]butanamide has 2 hydrogen bond donor(s) and 6 hydrogen bond acceptor(s), which may warrant consideration for formulation optimization.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of N-(4-chlorophenyl)-2-[[5-(3-phenylpropanoylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]butanamide?
The CAS number of N-(4-chlorophenyl)-2-[[5-(3-phenylpropanoylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]butanamide is 535948-24-4.
What is the molecular formula of N-(4-chlorophenyl)-2-[[5-(3-phenylpropanoylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]butanamide?
The molecular formula of N-(4-chlorophenyl)-2-[[5-(3-phenylpropanoylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]butanamide is C21H21ClN4O2S2.
What is the molecular weight of N-(4-chlorophenyl)-2-[[5-(3-phenylpropanoylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]butanamide?
The molecular weight of N-(4-chlorophenyl)-2-[[5-(3-phenylpropanoylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]butanamide is 460.08 g/mol.
Where can I buy N-(4-chlorophenyl)-2-[[5-(3-phenylpropanoylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]butanamide?
You can request a quote for N-(4-chlorophenyl)-2-[[5-(3-phenylpropanoylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]butanamide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for N-(4-chlorophenyl)-2-[[5-(3-phenylpropanoylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]butanamide?
Yes, KEHONG BIO provides custom synthesis services for N-(4-chlorophenyl)-2-[[5-(3-phenylpropanoylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]butanamide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.